. Moelle-Épinière-1, A. Compston, and A. Coles, Multiple sclerosis, Lancet. Apr, vol.6359, issue.9313, pp.1221-1252, 2002.

A. Compston and A. Coles, Multiple sclerosis. Lancet, pp.1502-1519, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00996686

D. Paty, J. Oger, L. Kastrukoff, S. Hashimoto, J. Hooge et al., MRI in the diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT, Neurology, vol.38, issue.2, pp.180-185, 1988.
DOI : 10.1212/WNL.38.2.180

F. Barkhof, M. Filippi, D. Miller, P. Scheltens, A. Campi et al., Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis, Brain, vol.120, issue.11, pp.2059-69, 1997.
DOI : 10.1093/brain/120.11.2059

L. Tartaglino, D. Friedman, A. Flanders, F. Lublin, R. Knobler et al., Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters., Radiology, vol.195, issue.3, 1995.
DOI : 10.1148/radiology.195.3.7754002

H. Link and Y. Huang, Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness, Journal of Neuroimmunology, vol.180, issue.1-2, pp.17-28, 2006.
DOI : 10.1016/j.jneuroim.2006.07.006

C. Lucchinetti, W. Brück, J. Parisi, B. Scheithauer, M. Rodriguez et al., Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination, Annals of Neurology, vol.143, issue.6, pp.707-724, 2000.
DOI : 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q

H. Lassmann, W. Brück, and C. Lucchinetti, The Immunopathology of Multiple Sclerosis: An Overview, Brain Pathology, vol.60, issue.2, pp.210-218, 2007.
DOI : 10.1016/S0896-6273(03)00326-X

B. Weinshenker, B. Bass, G. Rice, J. Noseworthy, W. Carriere et al., THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDY, Brain, vol.112, issue.1, pp.133-179, 1989.
DOI : 10.1093/brain/112.1.133

C. Confavreux, S. Vukusic, T. Moreau, and P. Adeleine, Relapses and Progression of Disability in Multiple Sclerosis, New England Journal of Medicine, vol.343, issue.20, pp.1430-1438, 2000.
DOI : 10.1056/NEJM200011163432001

A. Langer-gould, R. Popat, S. Huang, K. Cobb, P. Fontoura et al., Clinical and Demographic Predictors of Long-term Disability in Patients With Relapsing-Remitting Multiple Sclerosis, Archives of Neurology, vol.63, issue.12, pp.1686-91, 2006.
DOI : 10.1001/archneur.63.12.1686

P. Brex, O. Ciccarelli, O. Riordan, J. Sailer, M. Thompson et al., A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis, New England Journal of Medicine, vol.346, issue.3, pp.158-64, 2002.
DOI : 10.1056/NEJMoa011341

B. Weinshenker, B. Bass, G. Rice, J. Noseworthy, W. Carriere et al., THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDY, Brain, vol.112, issue.6, pp.1419-1447, 1989.
DOI : 10.1093/brain/112.6.1419

C. Confavreux, S. Vukusic, and P. Adeleine, Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process, Brain, vol.126, issue.4, pp.770-82, 2003.
DOI : 10.1093/brain/awg081

URL : https://hal.archives-ouvertes.fr/hal-00427394

A. Damasceno, V. Glehn, F. Brandão, C. Damasceno, B. Cendes et al., Prognostic indicators for long-term disability in multiple sclerosis patients, Journal of the Neurological Sciences, vol.324, issue.1-2, pp.29-33, 2013.
DOI : 10.1016/j.jns.2012.09.020

J. Kurtzke, Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS), Neurology, vol.33, issue.11, pp.1444-52, 1983.
DOI : 10.1212/WNL.33.11.1444

K. Johnson, B. Brooks, J. Cohen, C. Ford, J. Goldstein et al., Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind, placebo-controlled trial, Neurology, vol.45, issue.7, pp.1268-76, 1995.
DOI : 10.1212/WNL.45.7.1268

C. Polman, O. Connor, P. Havrdova, E. Hutchinson, M. Kappos et al., A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis, New England Journal of Medicine, vol.354, issue.9, pp.899-910, 2006.
DOI : 10.1056/NEJMoa044397

L. Kappos, E. Radue, O. Connor, P. Polman, C. Hohlfeld et al., A placebocontrolled trial of oral fingolimod in relapsing multiple sclerosis, N Engl J Med. 2010 Feb, vol.4362, issue.5, pp.387-401
URL : https://hal.archives-ouvertes.fr/hal-00617764

G. Filippini, F. Brusaferri, W. Sibley, A. Citterio, G. Ciucci et al., Corticosteroids or ACTH for acute exacerbations in multiple sclerosis, Cochrane Database Syst Rev, issue.4, p.1331, 2000.

A. Gafson, G. Giovannoni, and C. Hawkes, The diagnostic criteria for multiple sclerosis: From Charcot to McDonald, Multiple Sclerosis and Related Disorders, vol.1, issue.1, pp.9-14
DOI : 10.1016/j.msard.2011.08.002

G. Schumacher, G. Beebe, R. Kibler, I. Kurland, J. Kurtzke et al., PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS, Annals of the New York Academy of Sciences, vol.43, issue.6, pp.552-68, 1965.
DOI : 10.1111/j.1749-6632.1965.tb20235.x

C. Poser, D. Paty, L. Scheinberg, W. Mcdonald, F. Davis et al., New diagnostic criteria for multiple sclerosis: Guidelines for research protocols, Annals of Neurology, vol.122, issue.3, pp.227-258, 1983.
DOI : 10.1002/ana.410130302

W. Mcdonald, A. Compston, G. Edan, D. Goodkin, H. Hartung et al., Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis, Annals of Neurology, vol.70, issue.1, pp.121-128, 2001.
DOI : 10.1002/ana.1032

M. Tintore, A. Rovira, J. Rio, C. Nos, E. Grive et al., New diagnostic criteria for multiple sclerosis: Application in first demyelinating episode, Neurology, vol.60, issue.1, pp.27-30, 2003.
DOI : 10.1212/WNL.60.1.27

C. Polman, S. Reingold, G. Edan, M. Filippi, H. Hartung et al., Diagnostic criteria for multiple sclerosis: 2005 revisions to the ???McDonald Criteria???, Annals of Neurology, vol.6, issue.6, 2005.
DOI : 10.1002/ana.20703

J. Swanton, A. Rovira, M. Tintore, D. Altmann, F. Barkhof et al., MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study, The Lancet Neurology, vol.6, issue.8, pp.677-86, 2007.
DOI : 10.1016/S1474-4422(07)70176-X

C. Polman, S. Reingold, B. Banwell, M. Clanet, J. Cohen et al., Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, Annals of Neurology, vol.64, issue.suppl 2, 2011.
DOI : 10.1002/ana.22366

M. Sandberg-wollheim and T. Olsson, Cerebrospinal fluid oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: Yes, Multiple Sclerosis Journal, vol.19, issue.6, pp.714-720, 2013.
DOI : 10.1002/ana.22247

N. Koch-henriksen and P. Sørensen, The changing demographic pattern of multiple sclerosis epidemiology, The Lancet Neurology, vol.9, issue.5, pp.520-552
DOI : 10.1016/S1474-4422(10)70064-8

M. Trojano, G. Lucchese, G. Graziano, B. Taylor, S. Simpson et al., Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis, PLoS ONE, vol.76, issue.3, p.48078, 2012.
DOI : 10.1371/journal.pone.0048078.t003

J. Kurtzke, A REASSESSMENT OF THE DISTRIBUTION OF MULTIPLE SCLEROSIS, Acta Neurologica Scandinavica, vol.9, issue.Suppl. 147, pp.110-146, 1975.
DOI : 10.1111/j.1600-0404.1975.tb01364.x

N. Koch-henriksen and P. Sorensen, Why does the north???south gradient of incidence of multiple sclerosis seem to have disappeared on the Northern hemisphere?, Journal of the Neurological Sciences, vol.311, issue.1-2, pp.58-63, 2011.
DOI : 10.1016/j.jns.2011.09.003

A. Fromont, C. Binquet, E. Sauleau, I. Fournel, A. Bellisario et al., Geographic variations of multiple sclerosis in France, Brain, vol.133, issue.7, pp.1889-99, 2010.
DOI : 10.1093/brain/awq134

S. Orton, W. L. Confavreux, C. Vukusic, S. Krohn, J. Ramagopalan et al., Association of UV radiation with multiple sclerosis prevalence and sex ratio in France, Neurology, vol.76, issue.5, pp.425-456, 2011.
DOI : 10.1212/WNL.0b013e31820a0a9f

URL : https://hal.archives-ouvertes.fr/hal-00567871

M. Elian and G. Dean, Multiple sclerosis among the United Kingdom-born children of immigrants from the West Indies., Journal of Neurology, Neurosurgery & Psychiatry, vol.50, issue.3, pp.327-359, 1987.
DOI : 10.1136/jnnp.50.3.327

G. Dean and M. Elian, Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, vol.63, issue.5, pp.565-573, 1997.
DOI : 10.1136/jnnp.63.5.565

S. Hammond, D. English, and J. Mcleod, The age-range of risk of developing multiple sclerosis: Evidence from a migrant population in Australia, Brain, vol.123, issue.5, pp.968-74, 2000.
DOI : 10.1093/brain/123.5.968

P. Cabre, Migration and multiple sclerosis: The French West Indies experience, Journal of the Neurological Sciences, vol.262, issue.1-2, pp.117-138, 2007.
DOI : 10.1016/j.jns.2007.06.044

J. Sanchez, L. Palacio, C. Uribe, A. Londono, A. Villa et al., Clinical features of multiple sclerosis in a genetically homogeneous tropical population, Multiple Sclerosis Journal, vol.6, issue.4, pp.227-236, 2001.
DOI : 10.1177/135245850100700403

A. Ascherio and K. Munger, Environmental risk factors for multiple sclerosis. Part I: The role of infection, Annals of Neurology, vol.66, issue.suppl, pp.288-99, 2007.
DOI : 10.1002/ana.21117

A. Ascherio and K. Munger, Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors, Annals of Neurology, vol.108, issue.6, pp.504-517, 2007.
DOI : 10.1002/ana.21141

A. Compston, Genetic epidemiology of multiple sclerosis., Journal of Neurology, Neurosurgery & Psychiatry, vol.62, issue.6, pp.553-61, 1997.
DOI : 10.1136/jnnp.62.6.553

N. Patsopoulos, Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci, Annals of Neurology, vol.10, issue.6, pp.897-912, 2011.
DOI : 10.1002/ana.22609

P. Cabre, Role of return migration in the emergence of multiple sclerosis in the French West Indies, Brain, vol.128, issue.12, pp.2899-910, 2005.
DOI : 10.1093/brain/awh624

J. Vernant, L. Maurs, A. Gessain, F. Barin, O. Gout et al., Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: A clinical and seroepidemiological study of 25 cases, Annals of Neurology, vol.12, issue.suppl, pp.123-153, 1987.
DOI : 10.1002/ana.410210204

J. Vernant, P. Cabre, D. Smadja, H. Merle, I. Caubarrère et al., Recurrent Optic Neuromyelitis with Endocrinopathies: A New Syndrome, Neurology, vol.48, issue.1, pp.58-64, 1997.
DOI : 10.1212/WNL.48.1.58

C. Poser and J. Vernant, Multiple sclerosis in the black population]. Bull Société Pathol Exot, pp.428-460, 1990.

P. Cabre, Environmental changes and epidemiology of multiple sclerosis in the French West Indies, Journal of the Neurological Sciences, vol.286, issue.1-2, pp.58-61, 2009.
DOI : 10.1016/j.jns.2009.04.039

F. Dalmay, D. Bhalla, A. Nicoletti, J. Cabrera-gomez, P. Cabre et al., Multiple sclerosis and solar exposure before the age of 15 years: case???control study in Cuba, Martinique and Sicily, Multiple Sclerosis Journal, vol.117, issue.8, pp.899-908, 2010.
DOI : 10.1093/brain/123.6.1102

URL : https://hal.archives-ouvertes.fr/hal-00606425

D. Wingerchuk, W. Hogancamp, O. Brien, P. Weinshenker, and B. , The clinical course of neuromyelitis optica (Devic's syndrome), Neurology, vol.53, issue.5, pp.1107-1121, 1999.
DOI : 10.1212/WNL.53.5.1107

D. Wingerchuk and B. Weinshenker, Neuromyelitis optica: Clinical predictors of a relapsing course and survival, Neurology, vol.60, issue.5, pp.848-53, 2003.
DOI : 10.1212/01.WNL.0000049912.02954.2C

D. Wingerchuk, S. Pittock, C. Lucchinetti, V. Lennon, and B. Weinshenker, A secondary progressive clinical course is uncommon in neuromyelitis optica, Neurology, vol.68, issue.8, pp.603-608, 2007.
DOI : 10.1212/01.wnl.0000254502.87233.9a

A. Ghezzi, R. Bergamaschi, V. Martinelli, M. Trojano, M. Tola et al., Clinical characteristics, course and prognosis of relapsing Devic?s Neuromyelitis Optica, Journal of Neurology, vol.251, issue.1, pp.47-52, 2004.
DOI : 10.1007/s00415-004-0271-0

J. Rivera, J. Kurtzke, V. Booth, and T. Corona, Characteristics of Devic's disease (neuromyelitis optica) in Mexico, Journal of Neurology, vol.66, issue.5, pp.710-715, 2008.
DOI : 10.1007/s00415-008-0781-2

D. Bichuetti, E. Oliveira, N. Souza, R. Rivero, and A. Gabbai, Neuromyelitis optica in Brazil: a study on clinical and prognostic factors. Mult Scler, pp.613-622, 2009.

P. Cabre, A. González-quevedo, M. Bonnan, A. Saiz, S. Olindo et al., Relapsing neuromyelitis optica: long term history and clinical predictors of death, Journal of Neurology, Neurosurgery & Psychiatry, vol.80, issue.10, pp.1162-1166, 2009.
DOI : 10.1136/jnnp.2007.143529

N. Collongues, R. Marignier, H. Zephir, C. Papeix, F. Blanc et al., Neuromyelitis optica in France: A multicenter study of 125 patients, Neurology, vol.74, issue.9, pp.736-778, 2010.
DOI : 10.1212/WNL.0b013e3181d31e35

M. Nakamura, T. Nakazawa, H. Doi, T. Hariya, K. Omodaka et al., Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica, Graefe's Archive for Clinical and Experimental Ophthalmology, vol.111, issue.Suppl 4, pp.1777-85, 2010.
DOI : 10.1007/s00417-010-1344-7

T. Misu, K. Fujihara, I. Nakashima, S. Sato, and Y. Itoyama, Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica, Neurology, vol.65, issue.9, pp.1479-82, 2005.
DOI : 10.1212/01.wnl.0000183151.19351.82

T. Takahashi, I. Miyazawa, T. Misu, R. Takano, I. Nakashima et al., Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations, Journal of Neurology, Neurosurgery & Psychiatry, vol.79, issue.9, pp.1075-1083, 2008.
DOI : 10.1136/jnnp.2008.145391

A. Poppe, Y. Lapierre, D. Melançon, D. Lowden, L. Wardell et al., Neuromyelitis optica with hypothalamic involvement. Mult Scler, pp.617-638, 2005.

S. Viegas, A. Weir, M. Esiri, W. Kuker, P. Waters et al., Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica, Journal of Neurology, Neurosurgery & Psychiatry, vol.80, issue.6, pp.679-82, 2009.
DOI : 10.1136/jnnp.2008.157693

B. Carlander, T. Vincent, L. Floch, A. Pageot, N. Camu et al., Hypocretinergic dysfunction in neuromyelitis optica with coma-like episodes, Journal of Neurology, Neurosurgery & Psychiatry, vol.79, issue.3, pp.333-337, 2008.
DOI : 10.1136/jnnp.2007.135228

T. Baba, I. Nakashima, T. Kanbayashi, M. Konno, T. Takahashi et al., Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody, J Neurol, 2009.

S. Kim, W. Kim, X. Li, I. Jung, and H. Kim, Clinical spectrum of CNS aquaporin-4 autoimmunity, Neurology, vol.78, issue.15, pp.1179-85, 2012.
DOI : 10.1212/WNL.0b013e31824f8069

Y. Kanamori, I. Nakashima, Y. Takai, S. Nishiyama, H. Kuroda et al., Pain in neuromyelitis optica and its effect on quality of life: A cross-sectional study, Neurology, vol.77, issue.7, 2011.
DOI : 10.1212/WNL.0b013e318229e694

S. Pittock, V. Lennon, K. Krecke, D. Wingerchuk, C. Lucchinetti et al., Brain Abnormalities in Neuromyelitis Optica, Archives of Neurology, vol.63, issue.3, p.390, 2006.
DOI : 10.1001/archneur.63.3.390

S. Pittock, B. Weinshenker, C. Lucchinetti, D. Wingerchuk, J. Corboy et al., Neuromyelitis Optica Brain Lesions Localized at Sites of High Aquaporin 4 Expression, Archives of Neurology, vol.63, issue.7, p.964, 2006.
DOI : 10.1001/archneur.63.7.964

A. Mckeon, V. Lennon, T. Lotze, S. Tenenbaum, J. Ness et al., CNS aquaporin-4 autoimmunity in children, Neurology, vol.71, issue.2, pp.93-100, 2008.
DOI : 10.1212/01.wnl.0000314832.24682.c6

M. Bonnan, S. Olindo, A. Signate, S. Khaddam, D. Caparros-lefebvre et al., La neuromy??lite optique r??mittente: donn??es neuroradiologiques, Revue Neurologique, vol.162, issue.5, pp.595-602, 2006.
DOI : 10.1016/S0035-3787(06)75053-6

M. Levin, J. Bennett, and A. Verkman, Optic neuritis in neuromyelitis optica, Progress in Retinal and Eye Research, vol.36, pp.159-71, 2013.
DOI : 10.1016/j.preteyeres.2013.03.001

Y. Li, P. Xie, F. Lv, J. Mu, Q. Li et al., Brain magnetic resonance imaging abnormalities in neuromyelitis optica, Acta Neurologica Scandinavica, vol.13, issue.4, pp.218-243, 2008.
DOI : 10.1111/j.1600-0404.2008.01012.x

R. Mandler, L. Davis, D. Jeffery, and M. Kornfeld, Devic's neuromyelitis optica: A clinicopathological study of 8 patients, Annals of Neurology, vol.41, issue.2, pp.162-170, 1993.
DOI : 10.1002/ana.410340211

M. Filippi, M. Rocca, L. Moiola, V. Martinelli, A. Ghezzi et al., MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica, Neurology, vol.53, issue.8, pp.1705-1705, 1999.
DOI : 10.1212/WNL.53.8.1705

C. Cassinotto, H. Deramond, S. Olindo, M. Aveillan, D. Smadja et al., MRI of the spinal cord in neuromyelitis optica and recurrent longitudinal extensive myelitis, Journal of Neuroradiology, vol.36, issue.4, pp.199-205, 2009.
DOI : 10.1016/j.neurad.2008.12.008

W. Krampla, F. Aboul-enein, J. Jecel, W. Lang, E. Fertl et al., Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study, European Radiology, vol.60, issue.Pt 11, pp.2535-2578, 2009.
DOI : 10.1007/s00330-009-1425-3

C. Lucchinetti, R. Mandler, D. Mcgavern, W. Bruck, G. Gleich et al., A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica, Brain, vol.125, issue.7, pp.1450-61, 2002.
DOI : 10.1093/brain/awf151

T. Misu, R. Höftberger, K. Fujihara, I. Wimmer, Y. Takai et al., Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica, Acta Neuropathologica, vol.66, issue.6, pp.815-842, 2013.
DOI : 10.1007/s00401-013-1116-7

V. Lennon, D. Wingerchuk, T. Kryzer, S. Pittock, C. Lucchinetti et al., A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis, The Lancet, vol.364, issue.9451, pp.2106-2118, 2004.
DOI : 10.1016/S0140-6736(04)17551-X

V. Lennon, IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel, The Journal of Experimental Medicine, vol.43, issue.4, pp.473-480, 2005.
DOI : 10.1523/JNEUROSCI.1485-04.2004

T. Misu, K. Fujihara, A. Kakita, H. Konno, M. Nakamura et al., Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis, Brain, vol.130, issue.5, pp.1224-1258, 2007.
DOI : 10.1093/brain/awm047

S. Roemer, J. Parisi, V. Lennon, E. Benarroch, H. Lassmann et al., Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis, Brain, vol.130, issue.5, pp.1194-205, 2007.
DOI : 10.1093/brain/awl371

C. Sinclair, J. Kirk, B. Herron, U. Fitzgerald, and S. Mcquaid, Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter, Acta Neuropathologica, vol.109, issue.2, pp.187-94, 2007.
DOI : 10.1007/s00401-006-0169-2

S. Jarius, F. Paul, D. Franciotta, P. Waters, F. Zipp et al., Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica, Nature Clinical Practice Neurology, vol.68, issue.4, pp.202-216, 2008.
DOI : 10.1038/ncpneuro0764

R. Takano, T. Misu, T. Takahashi, S. Sato, K. Fujihara et al., Astrocytic damage is far more severe than demyelination in NMO: A clinical CSF biomarker study, Neurology, vol.75, issue.3, pp.208-224, 2010.
DOI : 10.1212/WNL.0b013e3181e2414b

P. Saikali, R. Cayrol, and T. Vincent, Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica, Autoimmunity Reviews, vol.9, issue.2, pp.132-137, 2009.
DOI : 10.1016/j.autrev.2009.04.004

S. Jarius, F. Aboul-enein, P. Waters, B. Kuenz, A. Hauser et al., Antibody to aquaporin-4 in the long-term course of neuromyelitis optica, Brain, vol.131, issue.11, 2008.
DOI : 10.1093/brain/awn240

S. Jarius, D. Franciotta, R. Bergamaschi, H. Wright, E. Littleton et al., NMO-IgG in the diagnosis of neuromyelitis optica, Neurology, vol.68, issue.13, pp.1076-1083, 2007.
DOI : 10.1212/01.wnl.0000256822.01222.bd

R. Fazio, M. Malosio, V. Lampasona, D. Feo, D. Privitera et al., Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Mult Scler Houndmills Basingstoke Engl, pp.1153-63, 2009.

I. Nakashima, Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG, Journal of Neurology, Neurosurgery & Psychiatry, vol.77, issue.9, pp.1073-1078, 2006.
DOI : 10.1136/jnnp.2005.080390

T. Matsuoka, T. Matsushita, Y. Kawano, M. Osoegawa, H. Ochi et al., Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese, Brain, vol.130, issue.5, pp.1206-1229, 2007.
DOI : 10.1093/brain/awm027

J. Cabrera-gomez, M. Bonnan, A. Gonzalez-quevedo, A. Saiz-hinarejos, R. Marignier et al., Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies, Multiple Sclerosis Journal, vol.201, issue.7, pp.828-861, 2009.
DOI : 10.1001/archneur.63.3.390

Y. Jiao, J. P. Fryer, V. Lennon, S. Jenkins, A. Quek et al., Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica, Neurology, vol.81, issue.14, pp.1197-2004, 2013.
DOI : 10.1212/WNL.0b013e3182a6cb5c

R. Bergamaschi, S. Tonietti, D. Franciotta, E. Candeloro, E. Tavazzi et al., Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations, Multiple Sclerosis, vol.10, issue.1, pp.2-4, 2004.
DOI : 10.1191/1352458504ms988oa

S. Luppe and N. Robertson, CSF ANALYSIS AND THE DIAGNOSIS OF NEUROMYELITIS OPTICA, Journal of Neurology, Neurosurgery & Psychiatry, vol.84, issue.11, p.2, 2013.
DOI : 10.1136/jnnp-2013-306573.21

S. Pittock, V. Lennon, J. De-seze, P. Vermersch, H. Homburger et al., Neuromyelitis Optica and Non???Organ-Specific Autoimmunity, Archives of Neurology, vol.65, issue.1, pp.78-83, 2008.
DOI : 10.1001/archneurol.2007.17

A. Mckeon, V. Lennon, A. Jacob, M. Matiello, C. Lucchinetti et al., Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve, pp.87-90, 2009.

N. Collongues, P. Cabre, R. Marignier, H. Zéphir, C. Papeix et al., A Benign Form of Neuromyelitis Optica, Archives of Neurology, vol.68, issue.7, pp.918-942, 2011.
DOI : 10.1001/archneurol.2011.127

R. Mandler, W. Ahmed, and J. Dencoff, Devic's neuromyelitis optica: A prospective study of seven patients treated with prednisone and azathioprine, Neurology, vol.51, issue.4, pp.1219-1239, 1998.
DOI : 10.1212/WNL.51.4.1219

A. Jacob, M. Matiello, B. Weinshenker, D. Wingerchuk, C. Lucchinetti et al., Treatment of Neuromyelitis Optica With Mycophenolate Mofetil, Archives of Neurology, vol.66, issue.9, p.1128, 2009.
DOI : 10.1001/archneurol.2009.175

S. Kim, Efficacy and Safety of Mitoxantrone in Patients With Highly Relapsing Neuromyelitis Optica<alt-title>Mitoxantrone for Highly Relapsing Neuromyelitis Optica</alt-title> Arch Neurol, p.473, 2011.

P. Cabre, S. Olindo, R. Marignier, S. Jeannin, H. Merle et al., Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study, Journal of Neurology, Neurosurgery & Psychiatry, vol.84, issue.5, pp.511-517, 2012.
DOI : 10.1136/jnnp-2012-303121

B. Cree, S. Lamb, K. Morgan, A. Chen, E. Waubant et al., An open label study of the effects of rituximab in neuromyelitis optica, Neurology, vol.64, issue.7, pp.1270-1272, 2005.
DOI : 10.1212/01.WNL.0000159399.81861.D5

A. Jacob, B. Weinshenker, I. Violich, N. Mclinskey, L. Krupp et al., Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients, Arch Neurol, vol.65, issue.11, p.1443, 2008.

G. Bedi, A. Brown, S. Delgado, N. Usmani, B. Lam et al., Impact of rituximab on relapse rate and disability in neuromyelitis optica, Multiple Sclerosis Journal, vol.17, issue.10, pp.1225-1255, 2011.
DOI : 10.1177/1352458511404586

S. Kim, W. Kim, X. Li, I. Jung, and H. Kim, Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years, Archives of Neurology, vol.68, issue.11, pp.1412-1432, 2011.
DOI : 10.1001/archneurol.2011.154

C. Papeix, J. Vidal, J. De-seze, C. Pierrot-deseilligny, A. Tourbah et al., Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler, pp.256-265, 2007.

Y. Shimizu, K. Yokoyama, T. Misu, T. Takahashi, K. Fujihara et al., Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis, Journal of Neurology, vol.66, issue.2, pp.305-312, 2007.
DOI : 10.1007/s00415-007-0730-5

J. Palace, M. Leite, A. Nairne, and A. Vincent, Interferon Beta Treatment in Neuromyelitis Optica, Archives of Neurology, vol.67, issue.8, pp.1016-1023, 2010.
DOI : 10.1001/archneurol.2010.188

A. Uzawa, M. Mori, S. Hayakawa, S. Masuda, and S. Kuwabara, Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis, European Journal of Neurology, vol.255, issue.5, pp.672-678, 2010.
DOI : 10.1111/j.1468-1331.2009.02897.x

A. Jacob, M. Hutchinson, L. Elsone, S. Kelly, R. Ali et al., Does natalizumab therapy worsen neuromyelitis optica? Neurology, pp.1065-1071, 2012.
DOI : 10.1212/wnl.0b013e31826845fe

I. Kleiter, K. Hellwig, A. Berthele, T. Kümpfel, R. Linker et al., Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica, Archives of Neurology, vol.69, issue.2, pp.239-284, 2012.
DOI : 10.1001/archneurol.2011.216

M. Barnett, J. Prineas, M. Buckland, J. Parratt, and J. Pollard, Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy. Mult Scler Houndmills Basingstoke Engl, pp.108-120, 2012.

J. Min, B. Kim, and K. Lee, Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder. Mult Scler Houndmills Basingstoke Engl, pp.113-118, 2012.

M. Bonnan, R. Valentino, S. Olindo, H. Mehdaoui, D. Smadja et al., Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder. Mult Scler Houndmills Basingstoke Engl, pp.487-92, 2009.

S. Watanabe, I. Nakashima, T. Misu, I. Miyazawa, Y. Shiga et al., Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler Houndmills Basingstoke Engl, pp.128-160, 2007.

S. Jarius and B. Wildemann, Noteomielite " accompanied by acute amaurosis (1844) An early case of neuromyelitis optica, J Neurol Sci Feb, vol.15313, issue.12, pp.182-186, 2012.

E. Devic, Myélite subaiguë compliquée de névrite optique, Bull Med (Paris), vol.8, pp.1033-1034, 1894.

O. 'riordan, J. Gallagher, H. Thompson, A. Howard, R. Kingsley et al., Clinical, CSF, and MRI findings in Devic's neuromyelitis optica., Journal of Neurology, Neurosurgery & Psychiatry, vol.60, issue.4, pp.382-389, 1996.
DOI : 10.1136/jnnp.60.4.382

D. Wingerchuk, V. Lennon, S. Pittock, C. Lucchinetti, and B. Weinshenker, Revised diagnostic criteria for neuromyelitis optica, American Journal of Ophthalmology, vol.142, issue.4, pp.1485-1494, 2006.
DOI : 10.1016/j.ajo.2006.08.010

D. Wingerchuk, V. Lennon, C. Lucchinetti, S. Pittock, and B. Weinshenker, The spectrum of neuromyelitis optica, The Lancet Neurology, vol.6, issue.9, pp.805-820, 2007.
DOI : 10.1016/S1474-4422(07)70216-8

M. Matiello, V. Lennon, A. Jacob, S. Pittock, C. Lucchinetti et al., NMO-IgG predicts the outcome of recurrent optic neuritis, Neurology, vol.70, issue.23, pp.2197-200, 2008.
DOI : 10.1212/01.wnl.0000303817.82134.da

D. Seze, J. Arndt, C. Jeanjean, L. Zephir, H. Blanc et al., Relapsing inflammatory optic neuritis: is it neuromyelitis optica? Neurology, pp.2075-2081, 2008.

N. Collongues, R. Marignier, H. Zephir, F. Blanc, S. Vukusic et al., High-risk syndrome for neuromyelitis optica: a descriptive and comparative study, Multiple Sclerosis Journal, vol.15, issue.6, 2011.
DOI : 10.1212/WNL.0b013e3181c1deb9

J. Kira, Multiple sclerosis in the Japanese population, The Lancet Neurology, vol.2, issue.2, pp.117-144, 2003.
DOI : 10.1016/S1474-4422(03)00308-9

B. Cree, O. Khan, D. Bourdette, D. Goodin, J. Cohen et al., Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis, Neurology, vol.63, issue.11, pp.2039-2084, 2004.
DOI : 10.1212/01.WNL.0000145762.60562.5D

P. Cabre, A. Gonzalez-quevedo, A. Lannuzel, M. Bonnan, H. Merle et al., Descriptive epidemiology of neuromyelitis optica in the Caribbean basin], Rev Neurol, 2009.

P. Phillips, N. Newman, and M. Lynn, Optic Neuritis in African Americans, Archives of Neurology, vol.55, issue.2, pp.186-92, 1998.
DOI : 10.1001/archneur.55.2.186

R. Papais-alvarenga, C. Miranda-santos, M. Puccioni-sohler, A. De-almeida, S. Oliveira et al., Optic neuromyelitis syndrome in Brazilian patients, Journal of Neurology, Neurosurgery & Psychiatry, vol.73, issue.4, pp.429-464, 2002.
DOI : 10.1136/jnnp.73.4.429

K. Lau, L. Wong, L. Li, Y. Chan, H. Li et al., Epidemiological study of multiple sclerosis in Hong Kong Chinese: questionnaire survey, Hong Kong Med J Xianggang Yi Xue Za Zhi Hong Kong Acad Med, vol.8, issue.2, pp.77-80, 2002.

A. Das and K. Puvanendran, A retrospective review of patients with clinically definite multiple sclerosis, pp.204-213, 1998.

S. Siritho, I. Nakashima, T. Takahashi, K. Fujihara, and N. Prayoonwiwat, AQP4 antibody-positive Thai cases: Clinical features and diagnostic problems, Neurology, vol.77, issue.9, pp.827-861, 2011.
DOI : 10.1212/WNL.0b013e31822c61b1

G. Gangopadhyay, S. Das, P. Sarda, S. Saha, P. Gangopadhyay et al., Clinical profile of multiple sclerosis in Bengal, Neurol India, vol.47, issue.1, pp.18-21, 1999.

M. Osoegawa, K. J. Fukazawa, T. Fujihara, K. Kikuchi, S. Matsui et al., Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years, Multiple Sclerosis, vol.15, issue.2, pp.159-73, 2009.
DOI : 10.1177/1352458508098372

N. Asgari, S. Lillevang, H. Skejoe, M. Falah, E. Stenager et al., A population-based study of neuromyelitis optica in Caucasians, Neurology, vol.76, issue.18, pp.1589-95, 2011.
DOI : 10.1212/WNL.0b013e3182190f74

M. Matiello, H. Kim, W. Kim, D. Brum, A. Barreira et al., Familial neuromyelitis optica, Neurology, vol.75, issue.4, pp.310-315, 2010.
DOI : 10.1212/WNL.0b013e3181ea9f15

M. Matiello, J. Schaefer-klein, D. Hebrink, D. Kingsbury, E. Atkinson et al., Genetic analysis of aquaporin-4 in neuromyelitis optica, Neurology, vol.77, issue.12, pp.1149-55, 2011.
DOI : 10.1212/WNL.0b013e31822f045b

H. Zephir, I. Fajardy, O. Outteryck, F. Blanc, N. Roger et al., Is neuromyelitis optica associated with human leukocyte antigen? Mult Scler, pp.571-580, 2009.

G. Brum, D. Barreira, A. Santos, A. Kaimen-maciel, D. Matiello et al., HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis, Multiple Sclerosis Journal, vol.16, issue.1, pp.21-30, 2009.
DOI : 10.1177/1352458509350741

R. Deschamps, L. Paturel, S. Jeannin, N. Chausson, S. Olindo et al., Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population, Multiple Sclerosis Journal, vol.189, issue.1, pp.24-31, 2011.
DOI : 10.1371/journal.pgen.0030150

K. Yamasaki, I. Horiuchi, M. Minohara, Y. Kawano, Y. Ohyagi et al., HLA-DPB1*0501-associated opticospinal multiple sclerosis: Clinical, neuroimaging and immunogenetic studies, Brain, vol.122, issue.9, pp.1689-96, 1999.
DOI : 10.1093/brain/122.9.1689

URL : http://doi.org/10.1093/brain/122.9.1689

T. Matsushita, T. Matsuoka, N. Isobe, Y. Kawano, M. Minohara et al., Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders Tissue Antigens, 2009.

J. Cabrera-gómez, J. Kurtzke, A. González-quevedo, and R. Lara-rodríguez, An epidemiological study of neuromyelitis optica in Cuba, Journal of Neurology, vol.66, issue.1, pp.35-44, 2009.
DOI : 10.1007/s00415-009-0009-0

J. Kitley, M. Leite, I. Nakashima, P. Waters, B. Mcneillis et al., Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan, Brain, vol.135, issue.6, pp.1834-1883
DOI : 10.1093/brain/aws109

D. Seze, J. Lebrun, C. Stojkovic, T. Ferriby, D. Chatel et al., Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler Houndmills Basingstoke Engl, pp.521-526, 2003.

B. Weinshenker, Neuromyelitis optica: what it is and what it might be, The Lancet, vol.361, issue.9361, pp.889-90, 2003.
DOI : 10.1016/S0140-6736(03)12784-5

B. Osuntokun, The pattern of neurological illness in tropical Africa, Journal of the Neurological Sciences, vol.12, issue.4, pp.417-459, 1971.
DOI : 10.1016/0022-510X(71)90110-9

M. Kaufman, S. Johnson, D. Moyer, J. Bivens, and H. Norton, Multiple Sclerosis, American Journal of Physical Medicine & Rehabilitation, vol.82, issue.8, pp.582-90, 2003.
DOI : 10.1097/01.PHM.0000078199.99484.E2

F. Fazekas, H. Offenbacher, S. Fuchs, R. Schmidt, K. Niederkorn et al., Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis, Neurology, vol.38, issue.12, pp.1822-1827, 1988.
DOI : 10.1212/WNL.38.12.1822

P. Cabre, S. Jeannin, S. Olindo, H. Merle, N. Chausson et al., Migration modifies disability progression in Afro-Carribean with multiple sclerosis

N. Chausson, S. Olindo, A. Signaté, D. Smadja, and P. Cabre, Evaluation of the 2005 McDonald MRI criteria for dissemination in space in Afro-Caribbean patients with clinically isolated syndromes, European Journal of Neurology, vol.77, issue.11, pp.1191-1197, 2009.
DOI : 10.1111/j.1468-1331.2009.02691.x

S. Jeannin, R. Deschamps, N. Chausson, and P. Cabre, Response to Interferon-Beta Treatment in Afro-Caribbeans with Multiple Sclerosis, Multiple Sclerosis International, vol.61, issue.2, p.950126, 2011.
DOI : 10.1001/archneurol.2008.47

S. Jeannin, M. Medjoubi, and P. Cabre, Response to natalizumab treatment in Afro-Caribbean with multiple sclerosis

B. Cree, A. Sabbagh, R. Bennett, and D. Goodin, Response to Interferon Beta-1a Treatment in African American Multiple Sclerosis Patients, Archives of Neurology, vol.62, issue.11, pp.1681-1684, 2005.
DOI : 10.1001/archneur.62.11.1681

B. Cree, W. Stuart, C. Tornatore, D. Jeffery, A. Pace et al., Efficacy of Natalizumab Therapy in Patients of African Descent With Relapsing Multiple Sclerosis, Archives of Neurology, vol.68, issue.4, pp.464-472, 2011.
DOI : 10.1001/archneurol.2011.45

J. Kira, T. Kanai, Y. Nishimura, K. Yamasaki, S. Matsushita et al., Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders, Ann Neurol, vol.40, issue.4, pp.569-74, 1996.

N. Isobe, T. Matsushita, R. Yamasaki, S. Ramagopalan, Y. Kawano et al., Influence of HLA-DRB1 alleles on the susceptibility and resistance to multiple sclerosis in Japanese patients with respect to anti-aquaporin 4 antibody status, Multiple Sclerosis Journal, vol.66, issue.2, pp.147-55, 2010.
DOI : 10.1016/S0165-5728(98)00074-5

J. Kira, Genetic and environmental backgrounds responsible for the changes in the phenotype of MS in Japanese subjects, Multiple Sclerosis and Related Disorders, vol.1, issue.4, pp.188-95, 2012.
DOI : 10.1016/j.msard.2012.05.003

T. Misu, K. Fujihara, M. Nakamura, K. Murakami, M. Endo et al., Loss of Aquaporin-4 in Active Perivascular Lesions in Neuromyelitis Optica: A Case Report, The Tohoku Journal of Experimental Medicine, vol.209, issue.3, 2006.
DOI : 10.1620/tjem.209.269

J. Kira, Neuromyelitis optica and opticospinal multiple sclerosis: Mechanisms and pathogenesis, Pathophysiology, vol.18, issue.1, pp.69-79, 2011.
DOI : 10.1016/j.pathophys.2010.04.008

T. Saida, K. Tashiro, Y. Itoyama, T. Sato, Y. Ohashi et al., Interferon beta-1b is effective in Japanese RRMS patients: A randomized, multicenter study, Neurology, vol.64, issue.4, pp.621-651, 2005.
DOI : 10.1212/01.WNL.0000151856.10387.E2

S. Okinaka, T. Tsubaki, Y. Kuroiwa, Y. Toyokura, and Y. Imamura, Multiple sclerosis and allied diseases in Japan: Clinical characteristics, Neurology, vol.8, issue.10, pp.756-63, 1958.
DOI : 10.1212/WNL.8.10.756

H. Shibasaki and Y. Kuroiwa, Clinical studies of multiple sclerosis in Japan. II. Are its clinical characteristics changing? Neurology, pp.618-640, 1973.

H. Shibasaki, Y. Kuroda, and Y. Kuroiwa, Clinical studies of multiple sclerosis in Japan, Journal of the Neurological Sciences, vol.23, issue.2, pp.215-237, 1974.
DOI : 10.1016/0022-510X(74)90224-X

B. Weinshenker, D. Wingerchuk, I. Nakashima, K. Fujihara, and V. Lennon, OSMS is NMO, but not MS: proven clinically and pathologically, The Lancet Neurology, vol.5, issue.2, pp.110-111, 2006.
DOI : 10.1016/S1474-4422(06)70333-7

S. Magana, S. Pittock, V. Lennon, B. Keegan, B. Weinshenker et al., Neuromyelitis Optica IgG Serostatus in Fulminant Central Nervous System Inflammatory Demyelinating Disease, Archives of Neurology, vol.66, issue.8, p.964, 2009.
DOI : 10.1001/archneurol.2009.152

G. Akman-demir, E. Tüzün, P. Waters, S. ?çöz, M. Kürtüncü et al., Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients, Journal of Neurology, vol.72, issue.Suppl.1, pp.464-70, 2010.
DOI : 10.1007/s00415-010-5780-4

R. Marignier, D. Sèze, J. Vukusic, S. Durand-dubief, F. Zéphir et al., NMO-IgG and Devic's neuromyelitis optica: a French experience, Multiple Sclerosis Journal, vol.59, issue.13, pp.440-445, 2008.
DOI : 10.1212/01.wnl.0000216139.44259.74

K. Chang, R. Lyu, C. Chen, Y. Wu, H. Chang et al., Distinct features between longitudinally extensive transverse myelitis presenting with and without antiaquaporin 4 antibodies, pp.299-307, 2013.

T. Scott, S. Kassab, and S. Pittock, Neuromyelitis Optica IgG Status in Acute Partial Transverse Myelitis, Archives of Neurology, vol.63, issue.10, p.1398, 2006.
DOI : 10.1001/archneur.63.10.1398

M. Tanaka, K. Tanaka, M. Komori, and T. Saida, Anti-aquaporin 4 antibody in Japanese multiple sclerosis: the presence of optic spinal multiple sclerosis without long spinal cord lesions and anti-aquaporin 4 antibody, Journal of Neurology, Neurosurgery & Psychiatry, vol.78, issue.9, pp.990-992, 2007.
DOI : 10.1136/jnnp.2006.114165

J. Bennett, C. Lam, S. Kalluri, P. Saikali, K. Bautista et al., Intrathecal pathogenic anti??????aquaporin-4 antibodies in early neuromyelitis optica, Annals of Neurology, vol.102, issue.5, pp.617-646, 2009.
DOI : 10.1002/ana.21802

M. Bradl, T. Misu, T. Takahashi, M. Watanabe, S. Mader et al., Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo, Annals of Neurology, vol.66, issue.5, pp.630-673, 2009.
DOI : 10.1002/ana.21837

M. Kinoshita, Y. Nakatsuji, T. Kimura, M. Moriya, K. Takata et al., Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells, Biochemical and Biophysical Research Communications, vol.394, issue.1, pp.205-215, 2010.
DOI : 10.1016/j.bbrc.2010.02.157

S. Saadoun, P. Waters, B. Bell, A. Vincent, A. Verkman et al., Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice, Brain, vol.133, issue.2, pp.349-61, 2010.
DOI : 10.1093/brain/awp309

N. Asgari, R. Khorooshi, S. Lillevang, and T. Owens, Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid, Journal of Neuroimmunology, vol.254, issue.1-2, pp.76-82, 2013.
DOI : 10.1016/j.jneuroim.2012.09.010

S. Hinson, S. Pittock, C. Lucchinetti, S. Roemer, J. Fryer et al., Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica, Neurology, vol.69, issue.24, pp.2221-2252, 2007.
DOI : 10.1212/01.WNL.0000289761.64862.ce

T. Takahashi, K. Fujihara, I. Nakashima, T. Misu, I. Miyazawa et al., Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre, Brain, vol.130, issue.5, pp.1235-1278, 2007.
DOI : 10.1093/brain/awm062

E. Moreh, I. Gartsman, D. Karussis, D. Rund, N. Hiller et al., Seronegative neuromyelitis optica: improvement following lymphocytapheresis treatment. Mult Scler Houndmills Basingstoke Engl, pp.860-861, 2008.

J. Kitley, M. Woodhall, P. Waters, M. Leite, E. Devenney et al., Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype, Neurology, vol.79, issue.12, 2012.
DOI : 10.1212/WNL.0b013e31826aac4e

S. Jarius, C. Probst, K. Borowski, D. Franciotta, B. Wildemann et al., Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen, Journal of the Neurological Sciences, vol.291, issue.1-2, pp.52-58, 2010.
DOI : 10.1016/j.jns.2010.01.002

P. Waters, A. Mckeon, M. Leite, S. Rajasekharan, V. Lennon et al., Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays, Neurology, vol.78, issue.9, 2012.
DOI : 10.1212/WNL.0b013e318248dec1

E. Klawiter, E. Alvarez, J. Xu, A. Paciorkowski, L. Zhu et al., NMO-IgG DETECTED IN CSF IN SERONEGATIVE NEUROMYELITIS OPTICA, Neurology, vol.72, issue.12, pp.1101-1104, 2009.
DOI : 10.1212/01.wnl.0000345066.57745.50

T. Matsushita, N. Isobe, H. Piao, T. Matsuoka, T. Ishizu et al., Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status, Journal of the Neurological Sciences, vol.291, issue.1-2, pp.37-43, 2010.
DOI : 10.1016/j.jns.2010.01.009

M. Rocca, F. Agosta, D. Mezzapesa, V. Martinelli, F. Salvi et al., Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica, Neurology, vol.62, issue.3, pp.476-484, 2004.
DOI : 10.1212/01.WNL.0000106946.08741.41

C. Yu, F. Lin, K. Li, T. Jiang, C. Zhu et al., Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica, AJNR Am J Neuroradiol, vol.27, issue.5, pp.1009-1024, 2006.
URL : https://hal.archives-ouvertes.fr/inria-00123601

Y. Liu, Y. Duan, Y. He, C. Yu, J. Wang et al., A tract-based diffusion study of cerebral white matter in neuromyelitis optica reveals widespread pathological alterations, Multiple Sclerosis Journal, vol.27, issue.7, pp.1013-1034, 2011.
DOI : 10.1007/s00330-006-0175-8

D. Seze, J. Blanc, F. Kremer, S. Collongues, N. Fleury et al., Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica, Journal of Neurology, Neurosurgery & Psychiatry, vol.81, issue.4, pp.409-420, 2010.
DOI : 10.1136/jnnp.2008.168070

F. Blanc, H. Zéphir, C. Lebrun, P. Labauge, G. Castelnovo et al., Cognitive Functions in Neuromyelitis Optica, Archives of Neurology, vol.65, issue.1, p.84, 2008.
DOI : 10.1001/archneurol.2007.16

F. Blanc, V. Noblet, B. Jung, F. Rousseau, R. F. Bourre et al., White Matter Atrophy and Cognitive Dysfunctions in Neuromyelitis Optica, PLoS ONE, vol.14, issue.4, p.33878, 2012.
DOI : 10.1371/journal.pone.0033878.t004

E. Saji, M. Arakawa, K. Yanagawa, Y. Toyoshima, A. Yokoseki et al., Cognitive impairment and cortical degeneration in neuromyelitis optica, Annals of Neurology, vol.122, issue.pt 7, p.2013
DOI : 10.1002/ana.23721

Y. Duan, Y. Liu, P. Liang, X. Jia, C. Yu et al., Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: A voxel-based morphometry study, European Journal of Radiology, vol.81, issue.2
DOI : 10.1016/j.ejrad.2011.01.065

J. Chanson, J. Lamy, F. Rousseau, F. Blanc, N. Collongues et al., White matter volume is decreased in the brain of patients with neuromyelitis optica, European Journal of Neurology, vol.82, issue.2, pp.361-368, 2013.
DOI : 10.1111/j.1468-1331.2012.03867.x

B. Popescu, J. Parisi, J. Cabrera-gómez, K. Newell, R. Mandler et al., Absence of cortical demyelination in neuromyelitis optica, Neurology, vol.75, issue.23, pp.2103-2112, 2010.
DOI : 10.1212/WNL.0b013e318200d80c

C. Lucchinetti, B. Popescu, R. Bunyan, N. Moll, S. Roemer et al., Inflammatory Cortical Demyelination in Early Multiple Sclerosis, New England Journal of Medicine, vol.365, issue.23, pp.2188-97, 2011.
DOI : 10.1056/NEJMoa1100648

S. Hinson, M. Romero, B. Popescu, C. Lucchinetti, J. Fryer et al., Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes, Proceedings of the National Academy of Sciences, vol.109, issue.4, pp.1245-50, 2012.
DOI : 10.1073/pnas.1109980108

T. Scott, Nosology of idiopathic transverse myelitis syndromes, Acta Neurologica Scandinavica, vol.64, issue.1, 2007.
DOI : 10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q

B. Ford, D. Tampieri, and G. Francis, Long-term follow-up of acute partial transverse myelopathy, Neurology, vol.42, issue.1, pp.250-252, 1992.
DOI : 10.1212/WNL.42.1.250

. Bakshi, . Kinkel, . Mechtler, . Bates, . Lindsay et al., Magnetic resonance imaging findings in 22 cases of myelitis: comparison between patients with and without multiple sclerosis, European Journal of Neurology, vol.240, issue.1, pp.35-48, 1998.
DOI : 10.1097/00004728-199605000-00022

T. Scott, E. Frohman, D. Seze, J. Gronseth, G. Weinshenker et al., Evidence-based guideline: Clinical evaluation and treatment of transverse myelitis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Neurology, vol.77, issue.24, pp.2128-2162, 2011.
DOI : 10.1212/WNL.0b013e31823dc535

T. Scott, S. Kassab, and S. Singh, Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis. Mult Scler Houndmills Basingstoke Engl, pp.373-380, 2005.

K. Chan, K. Tsang, G. Fong, S. Ho, R. Cheung et al., Idiopathic inflammatory demyelinating disorders after acute transverse myelitis, European Journal of Neurology, vol.31, issue.8, pp.862-870, 2006.
DOI : 10.1159/000064490

T. Matsuoka, T. Matsushita, M. Osoegawa, H. Ochi, Y. Kawano et al., Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings, Journal of the Neurological Sciences, vol.266, issue.1-2, pp.115-140, 2008.
DOI : 10.1016/j.jns.2007.09.010

I. Nakashima, T. Fukazawa, K. Ota, C. Nohara, Y. Warabi et al., Two subtypes of optic-spinal form of multiple sclerosis in Japan: clinical and laboratory features, Journal of Neurology, vol.7, issue.4, pp.488-92, 2007.
DOI : 10.1007/s00415-006-0400-z

T. Ishizu, K. J. Osoegawa, M. Fukazawa, T. Kikuchi, S. Fujihara et al., Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey, Journal of the Neurological Sciences, vol.280, issue.1-2, pp.22-30, 2009.
DOI : 10.1016/j.jns.2009.01.008

L. Kremer, M. Mealy, A. Jacob, I. Nakashima, P. Cabre et al., Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients, Multiple Sclerosis Journal, vol.20, issue.7, 2013.
DOI : 10.1177/1352458511431973

N. Losseff, D. Kingsley, W. Mcdonald, D. Miller, and A. Thompson, Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis. Mult Scler Houndmills Basingstoke Engl, Feb, vol.1, issue.4, pp.218-240, 1996.

N. Asgari, H. Skejoe, S. Lillevang, T. Steenstrup, E. Stenager et al., Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study, BMC Neurology, vol.1, issue.2, p.33, 2013.
DOI : 10.1007/s00330-009-1425-3

X. Zhong, H. Wang, J. Bao, R. Li, Y. Long et al., Relationship between neuromyelitis optica-IgG status and spinal cord magnetic resonance imaging in patients with neuromyelitis optica, Chin Med J (Engl, vol.125, issue.2, pp.270-274

S. Jarius, K. Ruprecht, B. Wildemann, T. Kuempfel, M. Ringelstein et al., Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients, Journal of Neuroinflammation, vol.76, issue.Pt 1, p.14, 2012.
DOI : 10.1186/1742-2094-9-14

J. Kira, K. Yamasaki, I. Horiuchi, Y. Ohyagi, T. Taniwaki et al., Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan, Journal of the Neurological Sciences, vol.166, issue.1, pp.53-60, 1999.
DOI : 10.1016/S0022-510X(99)00115-X

A. Villon, G. Foulon, R. Ancelle, N. Nguyen, and G. Martin-bouyer, Incident of intestinal parasitosis in Martinique]. Bull Société Pathol Exot Ses Fil, pp.406-422, 1983.

E. Gardien, L. Schlegel, N. Desbois, and R. Chout, Prevalence of intestinal parasitism in the public laboratories of Martinique: development from, pp.169-71, 1988.

D. Sewell, Z. Qing, E. Reinke, D. Elliot, J. Weinstock et al., Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization, International Immunology, vol.15, issue.1, pp.59-69, 2003.
DOI : 10.1093/intimm/dxg012

A. Mckee and E. Pearce, CD25+CD4+ Cells Contribute to Th2 Polarization during Helminth Infection by Suppressing Th1 Response Development, The Journal of Immunology, vol.173, issue.2, pp.1224-1255, 1950.
DOI : 10.4049/jimmunol.173.2.1224

A. Compston, 'The marvellous harmony of the nervous parts': The origins of multiple sclerosis, Clinical Medicine, vol.4, issue.4, pp.346-54, 2004.
DOI : 10.7861/clinmedicine.4-4-346

A. Cox, A. Coles, N. Antoun, O. Malik, C. Lucchinnetti et al., Recurrent myelitis and optic neuritis in a 29-year-old woman, The Lancet Neurology, vol.4, issue.8, pp.510-516, 2005.
DOI : 10.1016/S1474-4422(05)70143-5

A. Compston, Complexity and heterogeneity in demyelinating disease, Brain, vol.130, issue.5, pp.1178-80, 2007.
DOI : 10.1093/brain/awm092

L. Matthews, R. Marasco, M. Jenkinson, W. Küker, S. Luppe et al., Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution, Neurology, vol.80, issue.14, pp.1330-1337, 2013.
DOI : 10.1212/WNL.0b013e3182887957